Brief: Organon Q1 Adjusted EPS USD 0.71 Vs. IBES Estimate USD 0.83
30/04/2026 12:30
Apr 30 (Reuters) - Organon Q1 revenue USD 1,460 million vs. IBES estimate USD 1,484 million. Q1 EPS USD 0.55 Q1 gross margin 53.6% Q1 net income USD 146 million Q1 adjusted EBITDA USD 415 million Q1 adjusted net income USD 188 million vs. IBES estimate USD 212.8 million Q1 adjusted EBITDA margin 28.4%
Recent news on Organon & Co.
See all newsIndia's Sun Pharma misses debt fundraise goal as investors demand higher yields, bankers say
Brief: Organon & Co Says It Does Not Expect To Record Milestone Expense In Q3 2026
India's Persistent Systems plans debut rupee debt sale to fund acquisition, bankers say
India's Sun Pharma plans $1 billion local debt sale for loan takeout, sources say
Organon & Co reports results for the quarter ended June 30 - Earnings Summary